Spanish Red Biotech Pipeline

FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria)

Lentiviral vector

Type: Gene / Cell Therapy
Therapeutic area:
Indication: In vivo lentiviral gene therapy for the treatment of primary hyperoxaluria type 1
Phase: 2Regulatory Preclinical, 1Non Regulatory Preclinical